Kurosawa H, Ohki S, Joh T, Imai S, Matsuo K, Yamaguchi S, Fukano M, Hasegawa S, Tokitoh T, Masui H
2nd Dept. of Surgery, School of Medicine, Yokohama City University.
Gan To Kagaku Ryoho. 1991 Aug;18(11):1930-4.
Continuous arterial infusion chemotherapy using implantable reservoir was performed for unresectable liver metastases from colorectal cancer and the therapeutic effects, side effects and complications were evaluated. Eleven patients were treated with four kinds of arterial infusion courses that mainly consisted of 5-FU. The arterial infusion courses were discontinued in 2 patients because of nausea and vomiting, and in one patient because of diarrhea. The catheters were dislocated in 2 patients and another 2 developed fistulous between the hepatic artery and bile duct. Three patients developed duodenal ulcer. Serum CEA was reduced in 4 patients (36%). After all, response rate was 9% (1/11). The one-year survival rates of all cases and cases treated with more than 4 courses were 36.3% and 80.0%, respectively.
对无法切除的结直肠癌肝转移患者采用植入式储液器进行持续动脉灌注化疗,并评估其治疗效果、副作用和并发症。11例患者接受了主要由5-氟尿嘧啶组成的四种动脉灌注疗程治疗。2例患者因恶心和呕吐、1例患者因腹泻而停止动脉灌注疗程。2例患者导管移位,另外2例患者肝动脉与胆管之间形成瘘管。3例患者发生十二指肠溃疡。4例患者(36%)血清癌胚抗原降低。总体而言,缓解率为9%(1/11)。所有病例及接受超过4个疗程治疗病例的1年生存率分别为36.3%和80.0%。